Order Article Reprints

Steuer AE, Kaelin D, Boxler MI, Eisenbeiss L, Holze F, Vizeli P, Czerwinska J, Dargan PI, Abbate V, Liechti ME, et al. Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans. Metabolites. 2020; 10(8):306. https://doi.org/10.3390/metabo10080306

Steuer, Andrea E., Daria Kaelin, Martina I. Boxler, Lisa Eisenbeiss, Friederike Holze, Patrick Vizeli, Joanna Czerwinska, Paul I. Dargan, Vincenzo Abbate, Matthias E. Liechti, and et al. 2020. "Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans" Metabolites 10, no. 8: 306. https://doi.org/10.3390/metabo10080306

Steuer, A. E., Kaelin, D., Boxler, M. I., Eisenbeiss, L., Holze, F., Vizeli, P., Czerwinska, J., Dargan, P. I., Abbate, V., Liechti, M. E., & Kraemer, T. (2020). Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans. Metabolites, 10(8), 306. https://doi.org/10.3390/metabo10080306